1.3(top 50%)
impact factor
3.1K(top 10%)
papers
58.4K(top 5%)
citations
100(top 5%)
h-index
1.4(top 50%)
impact factor
4.9K
all documents
61.8K
doc citations
152(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1The Subgenual Anterior Cingulate Cortex in Mood DisordersCNS Spectrums2008920
2Mild Cognitive Impairment:An OverviewCNS Spectrums2008548
3Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side EffectsCNS Spectrums2005435
4SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of AntidepressantsCNS Spectrums2005409
5Functional Neuroimaging Studies of Human EmotionsCNS Spectrums2004402
6New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivityCNS Spectrums2014394
7Freeze, Flight, Fight, Fright, Faint: Adaptationist Perspectives on the Acute Stress Response SpectrumCNS Spectrums2004369
8Food and Drug Administration RegulationCNS Spectrums2008362
9Mechanism of Action of Trazodone:a Multifunctional DrugCNS Spectrums2009357
10The Prevalence of Body Dysmorphic Disorder in the United States Adult PopulationCNS Spectrums2008333
11The neurobiology of aggression and violenceCNS Spectrums2015313
12The Neurobiology of Substance and Behavioral AddictionsCNS Spectrums2006307
13The Precuneus and ConsciousnessCNS Spectrums2007302
14Hot and cold cognition in depressionCNS Spectrums2013287
15Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorderCNS Spectrums2015270
16Inflammation, Glutamate, and Glia in Depression:A Literature ReviewCNS Spectrums2008261
17Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHDCNS Spectrums2008256
18The role of reproductive hormones in postpartum depressionCNS Spectrums2015256
19Beyond Monoamines: Glutamatergic Function in Mood DisordersCNS Spectrums2005254
20Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to AntidepressantsCNS Spectrums2009254
21Conceptually Driven Pharmacologic Approaches to Acute TraumaCNS Spectrums2005236
22Potential Markers for Problematic Internet Use: A Telephone Survey of 2,513 AdultsCNS Spectrums2006235
23Psychiatric Comorbidity of Internet Addiction in College Students: An Interview StudyCNS Spectrums2008230
24Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of AntihistaminesCNS Spectrums2008228
25State of the science on mild cognitive impairment (MCI)CNS Spectrums2019228
26The Interplay of Neurotransmitters in Alzheimer's DiseaseCNS Spectrums2005217
27A Virtual Reality Scenario for All Seasons:The Virtual ClassroomCNS Spectrums2009213
28Risk of Recurrence of Depression During Long-Term Antidepressant TreatmentCNS Spectrums2007211
29Mechanism of action of pimavanserin in Parkinson’s disease psychosis: targeting serotonin 5HT2A and 5HT2C receptorsCNS Spectrums2016210
30Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypesCNS Spectrums2017210
31Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New DataCNS Spectrums2005197
32The Role of Glutamate in Anxiety and Related DisordersCNS Spectrums2005196
33Abuse and Neglect in Childhood: Relationship to Personality Disorder DiagnosesCNS Spectrums2003193
34Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic propertiesCNS Spectrums2014191
35Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesiaCNS Spectrums2016191
36Converting oral to long-acting injectable antipsychotics: a guide for the perplexedCNS Spectrums2017191
37Neurobiology of posttraumatic stress disorderCNS Spectrums2009191
38Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studiesCNS Spectrums2020178
39New Pharmacotherapeutic Approaches to Obsessive-Compulsive DisorderCNS Spectrums2009177
40Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patientsCNS Spectrums2014176
41Psychiatric Comorbidity in 36 Adults with Mitochondrial CytopathiesCNS Spectrums2007174
42Long-term effects of cariprazine exposure on dopamine receptor subtypesCNS Spectrums2014172
43The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the Assessment of Multiple Addictions in a High-School Population:Prevalence and Related DisabilityCNS Spectrums2006170
44Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamateCNS Spectrums2018170
45Defining and Diagnosing Involuntary Emotional Expression DisorderCNS Spectrums2006168
46Expanding the definition of addiction: DSM-5 vs. ICD-11CNS Spectrums2016167
47Sensory Phenomena in Obsessive-Compulsive Disorder and Tic Disorders: A Review of the LiteratureCNS Spectrums2008162
48Keeping Up with Clinical Advances: Opioid Use DisorderCNS Spectrums2019161
49Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD:A Randomized, Controlled TrialCNS Spectrums2006160
50Suicide in Bipolar Disorder: Risks and ManagementCNS Spectrums2006160